Univadis - a service form MSD

A trusted medical reference

Create an account Log in

app catalog Search

Log in

Close

My Account

Loading...

Medical News Medical Quiz eLearning Conference Reports Delete Oncology Radiology Collection Delete PubMed Delete Image & Media Library Delete Link Library Delete MSD Manual Delete Patient Resource Centre Install new apps

See all my apps Hide my apps

Install new apps Manage my apps

Rearrange your apps by dragging them or delete them with the cross.

Save Cancel

Welcome. Please log in or create an account.

Log in

Remember me (Uncheck if on a shared computer)

Forgot your Password ?

Please review the fields marked in red and resubmit the form

Create an account

Register to access independent medical news and resources from Univadis^®

Latest updates

Medical News

Medical reversals based on clinical studies published in JAMA, the Lancet and the New England Journal of Medicine.

Almost 400 common medical practices found ineffective

Univadis Medical News
14 June 2019

Medical reversals based on clinical studies published in JAMA, the Lancet and the New England Journal of Medicine.

Authorities are now working to contain the spread of the disease in Uganda after cases were identified there this week.

Experts convened to discuss Ebola outbreak after cases confirmed in Uganda

Univadis Medical News
14 June 2019

Authorities are now working to contain the spread of the disease in Uganda after cases were identified there this week.

Findings from a review of 29 trials in 12 countries.

Mixed exercise for fibromyalgia: Cochrane review

Univadis Medical News
14 June 2019

Findings from a review of 29 trials in 12 countries.

More Medical News >

Conference Reports

ASCO 2019 – Interview with Dr. Schilsky on this year’s patient-focused theme

Univadis
11 June 2019

An overview of the theme of ASCO 2019

ASCO 2019 — Enfortumab vedotin yields 44% response rate in advanced urothelial cancer

Oncology Conference reports
07 June 2019

Successful in patients resistant to checkpoint inhibitors.

ASCO 2019 — Acalabrutinib+obinutuzumab delivers high response in CLL

Oncology Conference reports
07 June 2019

Durable MRD negativity in peripheral blood.

More Conference Reports >

Featured Channels

application icon

Oncology Oncology essentials all in one place

application icon

Zika All you need to know about Zika virus

Keep up with oncology literature in minutes, every day

Get your daily dose of the latest evidence published in your cancer area of practice
Get my daily Newsletter

Univadis^®

Univadis^®, provided by MSD, brings you unbiased, relevant medical news as well as helpful resources for your daily practice at no cost.

Our Partners

Univadis^® brings together premium content publishers that deliver comprehensive and up-to-date medical information.

Contact Us

E-mail Us

Complete contact form >

MSD does not endorse and is not responsible for the accuracy of the content, or for practices or standards of non-MSD sources. Please read our Terms of Use for more information

Privacy Policy | Transparency Policy

Copyright © 2019 Aptus Health International, Inc. All rights reserved.